메뉴 건너뛰기




Volumn 41, Issue 2, 2002, Pages 157-167

High-dose chemotherapy in adult soft tissue sarcoma

Author keywords

Chemotherapy; Dose response relationship; High dose chemotherapy; Soft tissue sarcoma

Indexed keywords

ANTHRACYCLINE; ANTINEOPLASTIC AGENT; CYCLOPHOSPHAMIDE; DACARBAZINE; DACTINOMYCIN; DOCETAXEL; DOXORUBICIN; EPIRUBICIN; IFOSFAMIDE; VINCRISTINE;

EID: 0036169290     PISSN: 10408428     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1040-8428(01)00153-6     Document Type: Review
Times cited : (35)

References (57)
  • 1
    • 0032952928 scopus 로고    scopus 로고
    • Prognostic factors for the outcoma of chemotherapy in advanced soft tiisue sarcoma: an analysis of 2,185 patients treated with anthracycline-containing first-line regimens - A European Organisation for Research and Treatment of Cancer Soft Tissue and Bone Sarcoma Group Study
    • (1999) J. Clin. Oncol. , vol.17 , pp. 150-157
    • Van Glabbeke, M.1    van Oosterom, A.T.2    Oosterhuis, J.W.3
  • 3
    • 7844252263 scopus 로고    scopus 로고
    • High-dose epirubicin is not an alternative to standard-dose doxorubicin in the treatment of advanced soft tissue sarcomas. A study of the EORTC Soft Tissue and Bone Sarcoma Group
    • (1999) Br. J. Cancer , vol.78 , pp. 1634-1639
    • Nielsen, O.S.1    Dombernowsky, P.2    Mouridsen, H.3
  • 9
    • 0023243352 scopus 로고
    • Grade 3 nausea, vomiting, and myelosuppression or progressive, metastatic sarcoma?
    • (1987) J. Clin. Oncol. , vol.5 , pp. 881-889
    • Benjamin, R.S.1
  • 12
    • 0027256397 scopus 로고
    • Randomized comparison of doxorubicin alone versus ifosfamide plus doxorubicin or mitomycin, doxorubicin, and cisplatin against advanced soft tissue sarcomas
    • (1993) J. Clin. Oncol. , vol.11 , pp. 1269-1275
    • Edmonson, J.H.1    Ryan, L.M.2    Blum, R.H.3
  • 13
    • 0029005580 scopus 로고
    • Doxorubicin versus CYVADIC versus doxorubicin plus ifosfamide in first-line treatment of advanced soft tissue sarcomas: a randomized study of the European Organisation for Research and Treatment of Cancer Soft Tissue and Bone Sarcoma Group
    • (1995) J. Clin. Oncol. , vol.13 , pp. 1537-1545
    • Santoro, A.1    Tursz, T.2    Mouridsen, H.3
  • 17
    • 0023235065 scopus 로고
    • Combination chemotherapy using adriamycin, DTIC, cyclophosphamide, and actinomycin D for advanced soft tissue sarcomas: a randomized comparative trial. A phase III, Southwest Oncology Group Study (7613)
    • (1987) J. Clin. Oncol. , vol.5 , pp. 851-861
    • Baker, L.H.1    Frank, J.2    Fine, G.3
  • 26
    • 7344222584 scopus 로고    scopus 로고
    • Phase II trial of first-line high-dose ifosfamide in advanced soft tissue sarcomas of the adult: a study of the Spanish Group for Research on Sarcomas (GEIS)
    • (1998) Ann. Oncol. , vol.9 , pp. 871-876
    • Buesa, J.M.1    Lopez-Pousa, A.2    Martin, J.3
  • 32
    • 84907105824 scopus 로고
    • An assessment of the relative importance of the components of CYVADIC in the treatment of soft-tissue sarcomas using regression meta-analysis
    • (1994) Med. Inf. Lond. , vol.19 , pp. 311-321
    • Crawford, S.M.1    Jerwood, D.2
  • 36
    • 0027465117 scopus 로고
    • Granulocyte-macrophage colony-stimulating factor allows safe escalation of dose-intensity of chemotherapy in metastatic adult soft tissue sarcomas: a study of the European Organisation for Research and Treatmant of Cancer Soft Tissue and Bone Sarcoma Group
    • (1993) J. Clin. Oncol. , vol.11 , pp. 15-21
    • Steward, W.P.1    Verweij, J.2    Somers, R.3
  • 42
  • 55
    • 0030885437 scopus 로고    scopus 로고
    • A phase I/II study of sequential, dose-escalated, high dose ifosfamide plus doxorubicin with peripheral blood stem cell support for the treatment of patients with advanced soft tissue sarcomas
    • (1997) Cancer , vol.80 , pp. 1221-1227
    • Bokemeyer, C.1    Franzke, A.2    Hartmann, J.T.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.